NO20042967L - Fremgangsmate for rensing og/eller isolasjon av biologisk aktiv granulocyt-koloni-stimulerende-faktor - Google Patents

Fremgangsmate for rensing og/eller isolasjon av biologisk aktiv granulocyt-koloni-stimulerende-faktor

Info

Publication number
NO20042967L
NO20042967L NO20042967A NO20042967A NO20042967L NO 20042967 L NO20042967 L NO 20042967L NO 20042967 A NO20042967 A NO 20042967A NO 20042967 A NO20042967 A NO 20042967A NO 20042967 L NO20042967 L NO 20042967L
Authority
NO
Norway
Prior art keywords
csf
biologically active
isolation
stimulating factor
granulocyte colony
Prior art date
Application number
NO20042967A
Other languages
English (en)
Norwegian (no)
Inventor
Vladka Gaberc Porekar
Viktor Menart
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of NO20042967L publication Critical patent/NO20042967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO20042967A 2001-12-19 2004-07-14 Fremgangsmate for rensing og/eller isolasjon av biologisk aktiv granulocyt-koloni-stimulerende-faktor NO20042967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200100322A SI21102A (sl) 2001-12-19 2001-12-19 Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
PCT/EP2002/013810 WO2003051922A1 (fr) 2001-12-19 2002-12-05 Procede de purification et/ou d'isolation de facteur biologiquement actif de stimulation des colonies de granulocytes

Publications (1)

Publication Number Publication Date
NO20042967L true NO20042967L (no) 2004-09-07

Family

ID=20433022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042967A NO20042967L (no) 2001-12-19 2004-07-14 Fremgangsmate for rensing og/eller isolasjon av biologisk aktiv granulocyt-koloni-stimulerende-faktor

Country Status (21)

Country Link
US (1) US20050159589A1 (fr)
EP (2) EP1458757B1 (fr)
JP (1) JP4454311B2 (fr)
KR (1) KR20040071212A (fr)
CN (1) CN1606568A (fr)
AT (1) ATE423136T1 (fr)
AU (1) AU2002366275B2 (fr)
BR (1) BR0215191A (fr)
CA (1) CA2469984C (fr)
DE (1) DE60231243D1 (fr)
HR (1) HRP20040572A2 (fr)
HU (1) HUP0402547A3 (fr)
IL (2) IL162448A0 (fr)
MX (1) MXPA04006076A (fr)
NO (1) NO20042967L (fr)
NZ (1) NZ533305A (fr)
PL (1) PL207775B1 (fr)
RU (1) RU2358980C2 (fr)
SI (2) SI21102A (fr)
WO (1) WO2003051922A1 (fr)
ZA (1) ZA200404291B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
ATE322506T1 (de) * 2004-01-19 2006-04-15 Ares Trading Sa Verfahren zur reinigung von in bakterien exprimierten proteinen
WO2006030887A1 (fr) * 2004-09-17 2006-03-23 Cellgentech, Inc. Preparation externe pour le traitement des ulceres cutanes
EP1856147A4 (fr) * 2005-02-15 2008-07-02 Apollo Life Sciences Ltd Molécule et molécules chimères de celle-ci
US20080171857A1 (en) * 2005-03-17 2008-07-17 Uma Devi Komath Process for the Purification of Recombinant Granulocyte-Colony Stimulating Factor
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
DE102006009437A1 (de) 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
EP1878739A1 (fr) * 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. Purification de protéines en une étape par IMAC (MCAC)
WO2008096370A2 (fr) * 2007-02-05 2008-08-14 Natco Pharma Limited Méthode nouvelle et efficace de purification de hg-csf de recombinaison
US8546328B2 (en) 2007-08-27 2013-10-01 Biogenerix Ag Liquid formulation of G-CSF conjugate
JP2009073819A (ja) * 2007-08-29 2009-04-09 Fujifilm Corp 生理活性物質の精製方法
WO2010146599A1 (fr) * 2009-06-16 2010-12-23 Lupin Limited Procédé de purification du facteur de croissance hématopoïétique humain de recombinaison
SG176963A1 (en) 2009-06-22 2012-02-28 Amgen Inc Refolding proteins using a chemically controlled redox state
LT3660032T (lt) 2009-06-25 2026-02-25 Amgen Inc. Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai
EP2552948B1 (fr) * 2010-03-30 2016-07-13 Octapharma AG Procédé de purification de la protéine de facteur de croissance g-csf
EP2691411B1 (fr) 2011-03-29 2020-02-26 GlaxoSmithKline LLC Système tampon pour la purification protéique
CN103215340A (zh) * 2012-01-19 2013-07-24 江苏粒福特生物科技有限公司 一种新颖的粒细胞制备及其抗癌活性检测方法
HUP1200171A1 (hu) 2012-03-19 2013-09-30 Richter Gedeon Nyrt Módszerek polipeptidek elõállítására
HUP1200172A2 (en) 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227526A (ja) 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
EP0215126B1 (fr) 1985-02-08 1991-07-31 Chugai Seiyaku Kabushiki Kaisha Facteur de stimulation de colonies de granulocytes humains
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
DK203187A (da) 1986-04-22 1987-10-23 Immunex Corp Human g-csf proteinekspression
EP0719860B1 (fr) * 1988-05-13 2009-12-16 Amgen Inc. Processus en vue d'isoler et purifier G-CSF
US5055555A (en) 1989-01-05 1991-10-08 Helmut Sassenfeld Purification of G-CSF
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5932102A (en) 1998-01-12 1999-08-03 Schering Corporation Immobilized metal, affinity chromatography
FR2796071B1 (fr) * 1999-07-08 2001-09-07 Hoechst Marion Roussel Inc Procede de purification de facteur de stimulation de colonies de granulocytes

Also Published As

Publication number Publication date
CN1606568A (zh) 2005-04-13
SI1458757T1 (sl) 2009-10-31
IL162448A (en) 2010-12-30
PL207775B1 (pl) 2011-01-31
CA2469984C (fr) 2014-05-20
WO2003051922A1 (fr) 2003-06-26
HUP0402547A2 (hu) 2005-03-29
KR20040071212A (ko) 2004-08-11
CA2469984A1 (fr) 2003-06-26
RU2004121982A (ru) 2005-04-20
BR0215191A (pt) 2004-11-16
HK1064681A1 (en) 2005-02-04
HUP0402547A3 (en) 2010-01-28
EP1458757B1 (fr) 2009-02-18
MXPA04006076A (es) 2005-02-24
RU2358980C2 (ru) 2009-06-20
AU2002366275B2 (en) 2009-04-02
ZA200404291B (en) 2005-08-05
HRP20040572A2 (en) 2005-06-30
NZ533305A (en) 2005-11-25
JP2005525304A (ja) 2005-08-25
IL162448A0 (en) 2005-11-20
SI21102A (sl) 2003-06-30
JP4454311B2 (ja) 2010-04-21
EP2053061A1 (fr) 2009-04-29
ATE423136T1 (de) 2009-03-15
AU2002366275A1 (en) 2003-06-30
US20050159589A1 (en) 2005-07-21
PL369669A1 (en) 2005-05-02
DE60231243D1 (de) 2009-04-02
EP1458757A1 (fr) 2004-09-22

Similar Documents

Publication Publication Date Title
HRP20040572A2 (en) Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
JP4559216B2 (ja) 液体中の夾雑物からアルブミンを分離する方法、使用及びキット
DE60014047D1 (de) Verfahren zur reinigung von milchsäure auf industrieller basis
NO20050520L (no) Rensingav N,N-dimetylacetamdi
KR960007612A (ko) 재조합 사람 혈청 알부민의 정제방법
WO2023154822A8 (fr) Méthodes de purification d'un produit
DE50312257D1 (de) (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure
DE69939901D1 (de) Verfahren und materialien zur herstellung von glucosamin
CA2664855C (fr) Sorbant chiral hybride organique - inorganique et son processus de preparation
SK8592002A3 (en) Process for the purification of pharmacologically active proteins
ATE428728T1 (de) Verfahren zur reinigung von erythropoietin
DK1714982T3 (da) Fremgangsmåde til rensning af stærkt anioniske proteiner
ATE521600T1 (de) Verfahren zur herstellung von statinen
CA2210990A1 (fr) Nouveau procede combine pour la purification du chlorhydrate de vancomycine
KR100524872B1 (ko) 인터페론 베타의 정제방법
AU2003302418A1 (en) Method and apparatus for concentration and purification of nucleic acid
DE69001309D1 (de) Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
RU98123499A (ru) Способ очистки сырого продукта, содержащего циклоспориновый комплекс, циклоспорин а высокой чистоты и способ промышленного масштаба для очистки циклоспорина а
ATE461278T1 (de) Verfahren zur reinigung des modifizierten hauptallergens von milben
DE60233541D1 (de) Verfahren zur Reinigung von 5'-geschützten 2'-Deoxypurin Nukleosiden
ATE380197T1 (de) Verfahren zur reinigung von epi-hne proteinen
CN1902225A (zh) 纯化β－干扰素的方法
NO20052916L (no) Fremgangsmate for rensingen av TNF-bindende proteiner ved anvendelse av IMAC
Kim et al. Purification and Characterization of $\beta $-Xylosidase from Trichoderma sp. SY
WO2025186218A8 (fr) Purification et analyse d'arn

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application